Pharmacology, Toxicology and Pharmaceutical Science
Liver Fibrosis
100%
Human Serum Albumin
71%
Mannose 6 Phosphate
54%
Mouse
48%
Drug Carrier
39%
Platelet Derived Growth Factor Receptor
37%
Pharmacokinetics
35%
Receptor
34%
Platelet Derived Growth Factor Beta Receptor
33%
Fibrosis
33%
Sustained Release
28%
Microsphere
28%
Cytokine
25%
Disease
24%
Rho Kinase Inhibitor
24%
Drug Delivery System
21%
Albuminoid
20%
Gamma Interferon
19%
Interleukin 10
19%
Lactoferrin
19%
Somatomedin B Receptor
17%
Platelet Derived Growth Factor
15%
Doxorubicin
14%
Rho Kinase
14%
4 (1 Aminoethyl) N (4 Pyridyl)cyclohexanecarboxamide
14%
Neoplasm
14%
Cyclopeptide
14%
Liver Injury
14%
Platelet Derived Growth Factor BB
12%
Liver Cirrhosis
10%
Side Effect
10%
Anti-Human Immunodeficiency Virus
10%
Interferon
10%
HIV
10%
Adverse Event
9%
Cytomegalovirus Infection
9%
Gliotoxin
9%
Mycophenolic Acid
9%
Anticarcinogen
9%
Combination Therapy
9%
Phosphotransferase Inhibitor
9%
Carbon Tetrachloride
8%
Antivirus Agent
8%
Collagen Type 6
8%
Elimination
8%
Alkaline Phosphatase
8%
Transforming Growth Factor
8%
Mouse Model
7%
Liver Disease
7%
Haplorhini
7%
Medicine and Dentistry
Liver Fibrosis
51%
Hepatic Stellate Cell
47%
Fibrogenesis
29%
In Vitro
17%
Mannose 6 Phosphate
13%
Human Serum Albumin
12%
Disease
11%
Hepatocyte
11%
Osteoprotegerin
9%
Portal Venous Pressure
9%
Rho Kinase Inhibitor
9%
Interferon
9%
Platelet Derived Growth Factor Beta Receptor
9%
Fibrosis
9%
Stellate Cell
9%
Platelet Derived Growth Factor
9%
Receptor
8%
Alkaline Phosphatase
8%
Somatomedin B Receptor
7%
Transforming Growth Factor
7%
Liver Injury
7%
Liver Cirrhosis
7%
Rho Kinase
7%
Cytokine
6%
Myofibroblast
6%
Liver Slice
5%
Upregulation
5%
Side Effect
5%
Mediator
5%
Phosphotransferase Inhibitor
5%
Lipid A
5%
Keyphrases
Hepatic Stellate Cells
29%
Liver Fibrosis
26%
Fibrosis
20%
Platelet-derived Growth Factor Receptor (PDGFR)
19%
Antifibrotic
14%
Drug Carrier
13%
Myofibroblast
11%
Selective Delivery
11%
Selective Drugs
10%
Fibrogenesis
9%
Targeted Delivery
9%
Interferon-α (IFN-α)
9%
Platelet-derived Growth Factor β Receptor
9%
Fibrous Tissue
9%
Platelet-derived Growth factor-BB (PDGF-BB)
8%
Mannose-6-phosphate
7%
Albumin
7%
Sustained Release
7%
Fibrotic Liver
7%
Human Serum Albumin
6%
Human Liver
6%
Cyclic Peptide
5%
Kidney
5%
Unilateral Ureteral Obstruction
5%
Hepatic Stellate Cell Activation
5%
